文献速递心脑血管急症消化、代谢与肾脏急症

肌酐筛查对卒中CT造影后造影剂肾病的影响

Impact of creatinine screening on contrast-induced nephropathy following computerized tomography for stroke.
PubMed 文献 · Am J Emerg Med · 2020-09-20
一句话结论疑似急性卒中患者急诊增强CT前取消肌酐筛查未增加CIN、透析或死亡风险。

这项回顾性研究比较了急诊疑似急性卒中患者接受增强CT检查时,有无标准化肌酐筛查方案的两组人群。共纳入382例,筛查组186例,取消筛查组196例。主要终点CIN(48小时内血肌酐升高0.3 mg/dl或7天内升高至基线50%以上)两组无显著差异(7.0% vs 7.1%,OR 1.02,95%CI 0.47-2.24)。造影后30天以上肾功能损害、透析及死亡率均无显著差异,两组均无患者需要血液透析。提示在综合卒中中心,取消肌酐筛查未对临床结局产生不利影响。

要点

  • 取消肌酐筛查组CIN发生率7.1%,筛查组7.0%,差异无统计学意义(OR 1.02,95%CI 0.47-2.24)。
  • 造影后30天以上肾功能损害:筛查组8.4% vs 取消筛查组7.5%,OR 0.88(95%CI 0.38-2.07),无显著差异。
  • 首次就诊死亡率筛查组4.8% vs 取消筛查组2.6%(OR 0.51,95%CI 0.17-1.57),90天死亡率6.7% vs 4.0%(OR 0.58,95%CI 0.22-1.53),均无显著差异。
  • 两组均无患者需要血液透析。
  • 在综合卒中中心,取消增强CT前肌酐筛查未导致CIN、透析或死亡风险增加。

适用人群与场景

  • 急诊科疑似急性卒中并接受增强CT检查的患者。
  • 研究在综合卒中中心进行,纳入筛查组186例和取消筛查组196例。

诊断标准与关键阈值

  • CIN定义:造影剂给药后48小时内血清肌酐升高0.3 mg/dl或7天内升高至基线值的50%以上。
  • 其他定义基于原文未具体说明的CIN标准。
  • 肾功能损害定义为造影后30天以上出现的肾功能受损。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及需要立刻处理或不能漏诊的红旗征。

研究设计与关键结果

  • 研究类型:回顾性研究,比较急诊疑似急性卒中患者增强CT前有无标准化肌酐筛查方案。
  • 样本量:共382例,筛查组186例,取消筛查组196例。
  • 主要终点CIN发生率:筛查组7.0% vs 取消筛查组7.1%,差异0.1%(95%CI -5.6-5.1%),OR 1.02(95%CI 0.47-2.24),无显著差异。
  • 次要终点造影后30天以上肾功能损害:筛查组8.4% vs 取消筛查组7.5%,OR 0.88(95%CI 0.38-2.07),无显著差异。
  • 次要终点死亡率:首次就诊死亡率筛查组4.8% vs 取消筛查组2.6%,OR 0.51(95%CI 0.17-1.57);90天死亡率筛查组6.7% vs 取消筛查组4.0%,OR 0.58(95%CI 0.22-1.53),均无显著差异。
  • 两组均无患者需要血液透析。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限性:原文未述局限性。

对床旁实践的改变

  • 在综合卒中中心,急诊疑似急性卒中患者行增强CT前取消肌酐筛查未改变CIN、透析或死亡风险,可能支持省略该筛查。
  • 适用人群为急诊疑似急性卒中需增强CT者;原文未提及不适用人群。
  • 常见陷阱:原文未提及。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: This study sought to evaluate rates of acute kidney injury in patients undergoing contrast-enhanced computerized tomography for acute stroke in the emergency department (ED) before and after the cessation of creatinine screening.

METHODS: This retrospective study compared ED patients receiving contrast-enhanced imaging for suspected acute stroke with and without protocolized creatinine screening. The primary outcome was CIN, defined as an increase in serum creatinine of 0.3 mg/dl within 48 hours or 50% above baseline within 7 days after contrast administration. Secondary outcomes consisted of CIN based on other definitions, renal impairment greater than 30 days from contrast administration, hemodialysis, and mortality. Outcomes were compared using difference of proportions and odds ratios with 95% confidence intervals.

RESULTS: This study included 382 subjects, with 186 and 196 in the screening and post-screening cohorts, respectively. No significant differences were observed for CIN (7.0% vs 7.1%, difference 0.1% [95% CI -5.6-5.1%], OR 1.02 [95% CI 0.47-2.24]), renal impairment greater than 30 days post-contrast (8.4% vs 7.5%, OR 0.88 [0.38-2.07]), or mortality (index visit: 4.8% vs 2.6%, OR 0.51 [0.17-1.57], 90-day follow-up: 6.7% vs 4.0%, OR 0.58 [0.22-1.53]). No patients from either group required hemodialysis.

CONCLUSIONS: The elimination of creatinine screening prior to obtaining contrast-enhanced computerized tomography in patients with suspected acute stroke did not adversely affect rates of CIN, hemodialysis, or mortality at a comprehensive stroke center.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Becker BA, Yeich T, Jaffe JT, et al. Impact of creatinine screening on contrast-induced nephropathy following computerized tomography for stroke. Am J Emerg Med. 2020. PMID: 33051090. doi:10.1016/j.ajem.2020.09.044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。